Table 1 Baseline pre-operative and operative data of total study groups in patients who survive the first postoperative month after AVR
From: Obesity and the risk of late mortality after aortic valve replacement with small prosthesis
BMI < 24 | 24 ≤ BMI ≤ 27.9 | BMI ≥ 28 | |
|---|---|---|---|
n = 185 | n = 94 | n = 28 | |
Age, y | 56 ± 11.5 | 54 ± 14.7 | 57.8 ± 10.3 |
Sex (female),n (%) | 116 (64.4) | 44 (47.3)* | 19 (67.8)† |
Body surface area,m2 | 1.72 ± 0.32 | 1.78 ± 0.21* | 1.86 ± 0.28*† |
NYHA functional class, n (%) | |||
III | 85 (45.9) | 36 (38.3) | 13 (46.4) |
IV | 66 (35.7) | 28 (29.8) | 8 (28.6) |
LVEF, % | 49.6 ± 9.2 | 52.7 ± 7.8 | 51.8 ± 8.1 |
Pathology, n (%) | |||
Stenosis | 64 (34.6) | 26 (27.6) | 8 (28.6) |
Insufficiency | 20 (10.8) | 12 (12.8) | 6 (21.4)*† |
Mixed | 101 (54.6) | 56 (59.6) | 14 (50) |
Diabetes mellitus, n (%) | 26 (14.1) | 20 (21.2)* | 8 (28.6)*† |
Systemic hypertension, n (%) | 41 (22.1) | 28 (29.8)* | 13 (46.4)*† |
Chronic lung disease, n (%) | 21 (11.4) | 15 (15.9)* | 6 (21.4)*† |
AF, n (%) | 75 (40.5) | 28 (29.8)* | 9 (32.7)* |
Operative data | |||
Concomitant CABG | 30 (16.2) | 18 (19.1)* | 6 (21.4)*† |
EOAI,cm2/m2 | 1.07 ± 0.12 | 0.96 ± 0.08* | 0.81 ± 0.05*† |
CPB time, min | 100 ±31 | 104 ± 42 | 112 ± 28*† |
Mechanical prosthesis, % | 126 (68.5) | 54 (57.4) | 16 (57.1) |